cGxP.wire https://validator.w3.org/feed/docs/rss2.html DBV Technologies Screens First Infant in THRIVE Peanut Allergy Study Philips Gains FDA Clearance for AI Ultrasound Upgrade argenx Reports Long-Term Efgartigimod Benefits in Myositis and Sjogren’s Disease at EULAR 2026 Levicept’s LEVI-04 Shows Disease-Modifying Potential in Osteoarthritis Senzime Expands Pediatric Anesthesia Presence with New U.S. Hospital Contract Innovent’s IBI343 Shows Strong Efficacy in Phase III Study, Eyes Regulatory Approval CytomX and Regeneron Expand $4B Cancer Immunotherapy Alliance Lundbeck and Cradle Harness AI to Accelerate CNS Drug Discovery Alvotech Advances Key U.S. Biosimilars Toward FDA Review Australia Approves Amtagvi for Advanced Melanoma Care Philips and WellSpan Forge AI-Powered Healthcare Alliance Gilead’s Livdelzi Achieves Key Phase 3 PBC Trial Goal Xbrane Nears FDA Decision for Lucamzi Biosimilar Alnylam and Inceptive Forge $2B AI-RNAi Discovery Alliance Teva Launches AHZANTIVE Biosimilar to Eylea Across Europe RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak FDA Authorizes Signati Medical’s Multi-Center Trial for Separo System Servier Acquires Edgewise Muscular Dystrophy Business for $2.65B Oncolytics Reports Promising Pelareorep Data in RAS Cancers Travere Licenses Civorebrutinib in $1.14B Kidney Disease Deal AbbVie Secures EU Approval for AQUIPTA as Acute Migraine Treatment Evogene Reports Positive Phase 1 Data for BMC128 in Cancer SCIEX Launches AI-Powered Novus V55 Mass Spectrometry System AstraZeneca’s Camizestrant Extends Survival in ESR1-Mutant Breast Cancer Zenas BioPharma Reports Positive Phase 3 Obexelimab Results in IgG4-RD Resmed Completes Noctrix Health Acquisition to Expand Sleep Care Fulcrum Ends Pociredir Program After FDA Concerns Over Sickle Cell Therapy Lupin and Natco Win U.S. FDA Approval for Eribulin Injection Antengene Presents First ATG-207 Autoimmune Disease Data at EULAR 2026 Stelexis BioSciences Reports Breakthrough Phase 1 Eganelisib Results in AML and MDS AvenCell Therapeutics to Present First Phase 1 Results for Switchable Allogeneic CAR-T Therapy in AML Medtronic Expands Hugo Robotic Surgery System with New FDA Filings DHCG and Altruist Partner to Advance Biologics in China Sofinnova Partners Leads €13M Investment in AI Biology Startup Ingenix Ascidian and Lilly Sign $1.9B Kidney Disease RNA Deal Celcuity’s Gedatolisib Doubles Progression-Free Survival in Phase 3 Breast Cancer Trial Galmed and Tissue Dynamics Uncover Novel Pathway in Cardiac Fibrosis Telix and United Imaging Partner to Advance AI-Driven Theranostics Abivax’s Obefazimod Delivers Landmark Phase 3 Success in Ulcerative Colitis Alamar Launches NULISA Kit for Home-Based Proteomics ImmunityBio Highlights ANKTIVA Data in Lung and Bladder Cancer at ASCO 2026 SCIEX Expands ZenoTOF Platform with AI and Omics Research Innovations Alife Health Receives FDA Clearance for AI-Powered Embryo Selection Technology Johnson & Johnson’s Nipocalimab Shows Strong SLE Results Telix Presents Encouraging Phase 3 Results for TLX591-Tx at ASCO 2026 Ansun Biopharma Advances Phase 3 DAS181 Trial Following Positive DMC Review IDEAYA and Roche Advance Targeted Therapy for PDAC Cirius Therapeutics Highlights CIR-0602K as Promising New Therapy for Type 2 Diabetes Convergent’s CONV01-α Shows Promising Activity in Post-Lu-PSMA Prostate Cancer Phase 2 Study Agilent Expands FDA-Approved PD-L1 Testing for KEYTRUDA Across Four Cancer Types